Table 4.
SWOT analysis of lymph node navigation surgery.
| Strengths | Weaknesses |
|---|---|
| 1. Considerable number of clinical trials | 1.Controversy surrounds whether there is a survival benefit for progressive gastric cancer |
| 2. Selective lymph node dissection, preservation of function | 2.Non-tumour specific fluorescence, fluorescence is usually greater than the area of the sentinel lymph node |
| 3. ICG is easy to apply and has low side effects | 3.Metastatic lymph node acquisition rates do not appear to be increasing |
| 4. A broad perspective for fluoroscopy-guided surgery/laparoscopic systems | 4.High rate of false negatives in anterior lymph nodes |
| 5. High lymph node test count | 5.Difficulties in recognition after neoadjuvant therapy |
| Opportunities | Threats |
| 1. Selective lymph node dissection for early gastric cancer (D1/D1+) | 1.Differences in results between frozen pathology sections and permanent sections limit the accuracy of the extent of surgical excision |
| 2. Additional surgery after ESD can also be beneficial | 2.Long learning curve |
| 3. The concept of "lymph basin dissection” instead of "anterior lymph node dissection" | 3.ICG extra-cavity leakage, contaminating the operative area |
| 4. Three-dimensional simulation technology | 4.Specific probes to track gastric lymph nodes are questionable and lack preclinical/clinical studies, are expensive and have unproven safety |
| 5. Development of quantitative ICG software | 5.Other non-specific tracers are not superior to ICG and are expensive |